#USA #Conshohocken #Suvoda Greenphire Clinical Trials

Suvoda's Revolution: Streamlining Clinical Trials

In 2025, Suvoda, a trailblazer in clinical trial technology, took significant strides towards creating a seamless and connected clinical trial experience. The company's recent merger with Greenphire marked a transformative juncture, combining the strengths of both organizations to overcome enduring operational challenges faced by trial sites and patients alike. With a focus on unity, innovation, and the adoption of artificial intelligence tools, Suvoda aims to establish a single, user-friendly ecosystem that minimizes complexities throughout the clinical trial process.

A Shift in Experience

CEO Jagath Wanninayake emphasized the pivotal nature of 2025 for Suvoda, stating, "We dedicated the last year to integrating our technologies and people while remaining committed to delivering solutions that cater to the real needs of patients and sites." With the dawning of 2026, the company redirects its efforts towards offering clarity in trial navigation for sponsors and sites, while enhancing the overall experience for patients.

A landmark achievement this year was the introduction of Suvoda's patient app, which encapsulates various functions such as electronic Clinical Outcome Assessments (eCOAs), patient payments, reminders, and scheduling into a single, intuitive interface. Patients can now manage their journey through trials using their personal devices, which not only helps keep them engaged but also alleviates the administrative pressures faced by busy sites.

Harnessing AI for Efficiency

In a bid to reduce administrative burdens, Suvoda unveiled an innovative AI assistant named Sofia. Currently integrated into Suvoda's interactive response technology (IRT), Sofia offers a generative AI tool that simplifies how study teams access essential information. By replacing complex navigation processes with straightforward, instantaneous responses, Sofia empowers users to make informed decisions quickly, all while preserving rigorous data security and adherence to study protocols.

Suvoda's commitment to innovation in 2025 has not gone unnoticed, as the company secured a new patent for its platform architecture, raising its total to five. Moreover, it received recognition from the Everest Group as a Leader in the RTSM PEAK Matrix® assessment. Continuous improvements across its portfolio reflect Suvoda's emphasis on clarity, data integrity, and user-friendliness, ultimately aligning with its mission to support practical trial operations.

Looking Ahead to 2026

As Suvoda prepares for the coming year, it anticipates a surge in growth driven by an increasing demand from pharmaceutical sponsors and contract research organizations (CROs) for integrated platforms that simplify trial processes while enhancing patient and site experiences.

"2025 was not merely a year of transition but rather a period where we consolidated our technologies, personnel, and overarching goals," remarked Wanninayake. "This solid foundation positions us to unlock substantial value in 2026 and reach even more sponsors and sites with tailored solutions that empower patients seamlessly through their trial journey."

About Suvoda

Suvoda operates as a global leader in clinical trial technology, boasting a real-time software platform designed to enable sponsors and CROs to make confident decisions while ensuring sites and patients can take mindful, organized steps. Suvoda provides interconnected, action-oriented software solutions alongside exemplary services and support; this approach allows even the most time-sensitive and crucial studies to proceed effectively.

Based in the vicinity of Philadelphia, the company also maintains a presence in Portland, OR, Barcelona, Spain, Bucharest, and Iasi, Romania, as well as Tokyo, Japan. With consistently high customer satisfaction ratings that exceed industry benchmarks, Suvoda has been chosen by trial sponsors and CROs for more than 2,000 trials spanning across 95 countries. With the recent merger with Greenphire, a key player in clinical trial financial management and patient support, Suvoda is well-equipped to continue its upward trajectory in clinical trial innovation. Those interested can learn more about Suvoda via their website at suvoda.com or by following them on LinkedIn.